Surgery Partners, Inc. — Revenue by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/1a07a6e5-d872-42e6-bef8-4527b127722f/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $3.3B | 2025-01-01 – 2025-12-31 | evidence 0001638833-26-000008 |
| FY 2024 | $3.1B | 2024-01-01 – 2024-12-31 | evidence 0001638833-25-000053 |
| FY 2023 | $2.7B | 2023-01-01 – 2023-12-31 | evidence 0001638833-24-000029 |
| FY 2022 | $2.5B | 2022-01-01 – 2022-12-31 | evidence 0001638833-23-000021 |
| FY 2021 | $2.2B | 2021-01-01 – 2021-12-31 | evidence 0001638833-22-000019 |
| FY 2020 | $1.9B | 2020-01-01 – 2020-12-31 | evidence 0001638833-21-000034 |
| FY 2019 | $1.8B | 2019-01-01 – 2019-12-31 | evidence 0001638833-20-000012 |
| FY 2018 | $1.8B | 2018-01-01 – 2018-12-31 | evidence 0001638833-20-000012 |
| FY 2016 | $1.1B | 2016-01-01 – 2016-12-31 | evidence 0001638833-19-000006 |
| FY 2015 | $959.9M | 2015-01-01 – 2015-12-31 | evidence 0001638833-16-000019 |
| FY 2014 | $403.3M | 2014-01-01 – 2014-12-31 | evidence 0001638833-16-000019 |
| FY 2013 | $284.6M | 2013-01-01 – 2013-12-31 | evidence 0001638833-16-000019 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Surgery Partners, Inc. — all facts · Net Income · Operating Income